Home / Import refusals / 8JB-0093850-4/11/39

8JB-0093850-4/11/39

Teva Pharmaceuticals USA, Inc — FEI 3003092769

Recent inspections

  • 1258587 (NAI Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219319 (VAI Fri Sep 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1160882 (NAI Thu Dec 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 703036 (VAI Thu Dec 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 645466 (VAI Mon Mar 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-1116285-8/11/1 (Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 9SN-0007009-6/171/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-4554397-0/71/1 (Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/2 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/4 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
March 22, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
62YDA07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
Charges
179